[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349104-105":59,"doc-detail-349104-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-molecular-pathology-of-blood-cancer-a-comprehensive-review-of-chromosome-and-genetic-abnormalities-and-their-clinical-utility","The Molecular Pathology of Blood Cancer - A Comprehensive Review of Chromosome and Genetic Abnormalities and Their Clinical Utility","","Molecular pathology has reshaped blood-cancer understanding through highly sensitive technologies such as next- and third-generation sequencing and whole-exome sequencing, complemented by bioinformatics. These approaches clarify chromosomal and gene abnormalities and strengthen links between cellular biology, aetiology, classification, and pathophysiology. The review catalogues discoveries that improve diagnosis and management, including targeted treatment of aberrant tyrosine kinase activity and prognostic stratification for severe outcomes. It surveys implications across lymphoma, leukaemia, myeloma, and related neoplasms, anticipating continued advances as new methods emerge.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-molecular-pathology-of-blood-cancer-a-comprehensive-review-of-chromosome-and-genetic-abnormalities-and-their-clinical-utility/349104/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-molecular-pathology-of-blood-cancer-a-comprehensive-review-of-chromosome-and-genetic-abnormalities-and-their-clinical-utility/349104.png","ImageObject",300,407,{"name":92,"@type":93},"Aditya","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which sequencing and bioinformatics methods are highlighted for studying blood cancer?","Question",{"text":112,"@type":113},"The review highlights next- and third-generation sequencing and whole exome sequencing, alongside bioinformatics, to determine chromosomal and gene abnormalities with high sensitivity and specificity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does molecular pathology support diagnosis and treatment decisions in blood cancer?",{"text":117,"@type":113},"It improves diagnosis and management by enabling recognition of actionable abnormalities, such as aberrant tyrosine kinase activity for targeted inhibitors, and by linking certain abnormalities to more severe outcomes for focused treatment.",{"name":119,"@type":110,"acceptedAnswer":120},"What historical milestones does the review describe for understanding blood cancer genetics?",{"text":121,"@type":113},"It traces early findings from nuclein (1871) and early descriptions of blood cancers, then discusses key analytical developments including cytogenetics and later molecular approaches that identified sequence homology and chromosomal translocations associated with specific blood-cancer forms.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349104,1790545158,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":24,"preview_urls":146},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","*Correspondence  \nA. D. Blann,  \n [andrewblann@ibms.org](andrewblann@ibms.org)[ ](andrewblann@ibms.org)†These authors have contributed equally to this work  \nReceived: 09 April 2025  \nRevised: 10 December 2025  \nAccepted: 23 December 2025  \nPublished: 20 April 2026  \nCitation:  \nMcCaul N, Bingham RJ and BlannAD (2026) The Molecular Pathology of Blood Cancer: A Comprehensive Review of Chromosome and Genetic Abnormalities and Their Clinical Utility.  \nBr. J. Biomed. Sci. 82:14745.  \ndoi: 10.3389/bjbs.2025.14745  \nThe Molecular Pathology of Blood Cancer: A Comprehensive Review of Chromosome and Genetic Abnormalities and Their Clinical Utility  \nN. McCaul†, R. J. Bingham† and A. D. Blann *  \nDepartment of Applied Sciences, Huddersfield University, Huddersfield, United Kingdom  \nMolecular pathology has, without a doubt, transformed the field of blood cancer. Thanks to pioneers such as Sanger and Mullis, techniques such as next- and third-generation sequencing, and whole exome sequencing have, alongside a revolution in bioinformatics, determined abnormalities in chromosomes and genes with exquisite sensitivity and specificity. These have contributed considerably not just to our understanding of the cell biology, aetiology, classification, and pathophysiology of blood cancer, but also to its diagnosis and management. Good examples of this include the ability to recognise and treat cases of aberrant tyrosine kinase activity with targeted inhibitors and the recognition that certain abnormalities are linked to a more severe outcome, so that focused treatment can begin. This review catalogues these discoveries and describes how they contribute to our understanding of, and thus the treatment of, lymphoma, leukaemia, myeloma, and other myeloproliferative, erythroid, megakaryocytic, and lymphoid neoplasms. Inevitably, as new techniques are developed, we can expect further advances in biomedical science in all aspects of blood cancer.  \nKeywords: blood cancer, leukaemia, lymphoma, molecular pathology, myeloma  \nINTRODUCTION  \nEach year, the UK’s Office for National Statistics (ONS) publishes data on the leading causes of death [ 1]. In 2023, of the 580,108 deaths in England and Wales, 152,418 (26.3%, the leading cause) were due to malignant neoplasms, and of these, those of the lung, bronchus and trachea were the most common (27,856: 18.32%), followed by cancer of the colon and rectum (15,527: 10.2%) . The third most frequent cause of a cancer death is cancer of the lymphoid, haematopoietic and related tissues, i.e., blood cancer, with 12,193 deaths, exceeding those of prostate (11,072) and breast cancers (9,973) . As genetics are implicated in the aetiology of cancer [2], this narrative review will summarise leading aspects of the role of chromosomal and genetic molecular pathology in the diagnosis and treatment of blood cancer. We will address this issue first with a historical perspective and then move on to the role of genetics in blood cancer subtypes. In doing so, we will adopt the standard shorthand notations for describing the leading chromosomal and genetic abnormalities (Table 1) .  \nBritish Journal of Biomedical Science | Published by Frontiers 1 April 2026 | Volume 82 | Article 14745  \nTABLE 1 | Shorthand descriptors of the most common chromosomal and genetic abnormalities.  \n\n| Shorthand example | Meaning |\n| --- | --- |\n| +8 | An extra copy of chromosome 8, and so a trisomy |\n| −7 | Loss of an entire chromosome 7, and so a monosomy |\n| −13q | Loss of the q arm of chromosome 13 |\n| i(17q) | Loss of the p arm of chromosome 17 and its replacement by the q arm, and so two q arms. |\n| t(9;22)(q34;q11) | Translocation of q34 from chromosome 9 to the q11 region of chromosome 22 |\n| del(17p) | Deletion of the p arm of chromosome 17 |\n| inv(3)(q21; q26) | Inversion of section q21 to q26 of chromosome 3 |\n| iAMP21 | Intrachromosomal amplification of chromosome 21 |\n| BCR::ABL1 | Fusion gene of BCR and ABL1 |\n\nHISTORICAL PERSPECTIVE  \nGiv","cbCaicntfPh6kRUk","https://ap.wps.com/l/cbCaicntfPh6kRUk","pdf",3841344,43,"English","# Introduction\n## Historical Perspective\n## Table 1: Shorthand descriptors of common chromosomal and genetic abnormalities","[{\"question\":\"Which sequencing and bioinformatics methods are highlighted for studying blood cancer?\",\"answer\":\"The review highlights next- and third-generation sequencing and whole exome sequencing, alongside bioinformatics, to determine chromosomal and gene abnormalities with high sensitivity and specificity.\"},{\"question\":\"How does molecular pathology support diagnosis and treatment decisions in blood cancer?\",\"answer\":\"It improves diagnosis and management by enabling recognition of actionable abnormalities, such as aberrant tyrosine kinase activity for targeted inhibitors, and by linking certain abnormalities to more severe outcomes for focused treatment.\"},{\"question\":\"What historical milestones does the review describe for understanding blood cancer genetics?\",\"answer\":\"It traces early findings from nuclein (1871) and early descriptions of blood cancers, then discusses key analytical developments including cytogenetics and later molecular approaches that identified sequence homology and chromosomal translocations associated with specific blood-cancer forms.\"}]","The Molecular Pathology of Blood Cancer - A Comprehensive Review of Chromosome and Genetic Abnormalities and Their Clinical Utility | PDF",1790081650,108,[147,151,155,159,163],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20aa7e0099a46f9002329861b781af74.webp",983,1287,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38865cc06c57badc0e53ed4a8344f4ae.webp",982,1286,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57456dff4f2eaf4557330980b4abb51a.webp",981,1284,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72d68b371e3b8efd80e46f5076e4b54e.webp",980,1283,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a07cd859d8ae0e459c7434b4a74e81a.webp",979,1282]